$NUS
NuSkin Enterprises, Inc.
XNYS•Industrials•Wholesale-Drugs, Proprietaries & Druggists' Sundries
$4.98
▲+0.20%+$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateNuSkin Enterprises, Inc.
XNYS•Industrials•Wholesale-Drugs, Proprietaries & Druggists' Sundries
Why is NUS up today? It is at $4.98 (+0.20%), and our scanner flagged it 18 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NUS spikes, and full due diligence on NUS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $NUS 18 times in the last 30 days. Create a free account to track $NUS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on NUS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NUS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing4Statement of changes in beneficial ownership of securitiesSep 10, 2026 · 40 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Woodbury Edwina D Director | Acquired (grant/award) | +22 | added <0.1% | 62K | $107 at $4.85 | Sep 9, 26 |
Woodbury Edwina D Director | Acquired (grant/award) | +19 | added <0.1% | 62K | $103 at $5.43 | Jun 10, 26 |
Winett James M Director | Sold (automatic/other) | -7K 0.01% of company | sold 16% | 37K | $40K at $5.62 | Jun 2, 26 |
Campbell Daniel W Director | Acquired (grant/award) | +27K 0.05% of company | added 68% | 66K | n/a | Jun 1, 26 |
Thomas Pisano R. Director | Acquired (grant/award) | +27K 0.05% of company | added 30% | 117K | n/a | Jun 1, 26 |
Battle Emma S. Director | Acquired (grant/award) | +27K 0.05% of company | added 86% | 58K | n/a | Jun 1, 26 |
Woodbury Edwina D Director | Acquired (grant/award) | +27K 0.05% of company | added 62% | 70K | n/a | Jun 1, 26 |
Woodbury Edwina D Director | Sold (automatic/other) | -7K 0.01% of company | sold 10% | 62K | $41K at $5.70 | Jun 1, 26 |
Zorko Mark A Director | Acquired (grant/award) | +27K 0.05% of company | added 78% | 61K | n/a | Jun 1, 26 |
Nathanson Laura Director | Acquired (grant/award) | +27K 0.05% of company | added 87% | 57K | n/a | Jun 1, 26 |
Winett James M Director | Acquired (grant/award) | +27K 0.05% of company | added 100% | 45K | n/a | Jun 1, 26 |
Nathanson Laura Director | Sold (automatic/other) | -3K | sold 8.1% | 30K | $18K at $6.73 | May 11, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in wholesale-drugs, proprietaries & druggists' sundries, closest in size first.
Here is the latest on NUS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NUS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
NUS last traded at $4.98, up 0.20% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
NuSkin Enterprises, Inc. (NUS) is next expected to report earnings on Thursday, November 5, 2026, about 16 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. NUS currently has a dividend yield of about 4.83% ($0.24 per share per year). Dividend figures can change; this is not investment advice.
The NUS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NUS 18 times in the last 30 days.
NUS (NuSkin Enterprises, Inc.) trades on XNYS, with a market cap of about $242M in the Wholesale-Drugs, Proprietaries & Druggists' Sundries sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NUS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NUS discussion
Sign in to ask a question or join the discussion.